Pfizer deal clarifies drug price overhang
The guest from BMO argued that the new deal between Pfizer and the government provides clarity on drug pricing, which was a key overhang on the sector, and is viewed positively by investors.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.